P39 Polyclonal Antibody

Rabbit Anti-p39 Polyclonal Antibody

Product Specifications

Background

Cyclin dependent kinase 5 regulatory subunit 2 encoded by CDK5R2 is a neuron-specific activator of CDK5 kinase. It associates with CDK5 to form an active kinase. Cyclin dependent kinase 5 regulatory subunit 2 and neuron-specific CDK5 activator CDK5R1/p39NCK5A both share limited similarity to cyclins, and thus may define a distinct family of cyclin-dependent kinase activating proteins.

CAS Number

9007-83-4

Product Name Alternative

CDK5R2; NCK5AI; Cyclin-dependent kinase 5 activator 2; CDK5 activator 2; Cyclin-dependent kinase 5 regulatory subunit 2; p39; p39I

Gene ID

8941

Accession Number

Q13319

Reactivity

Human, Mouse

Immunogen

Synthesized peptide derived from the Internal region of human p39 at AA range: 50-130

Clonality

Polyclonal

Tag

Cyclin-dependent kinase 5 activator 2

Applications

WB, IHC, IF, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

40kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

P39 Polyclonal Antibody detects endogenous levels of p39 protein.

Observed Molecular Weight

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000; IHC 1:100-1:300; ELISA 1:20000; IF 1:50-200